Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs
American Journal of Veterinary Research · 2026
DOI: 10.2460/ajvr.26.03.0100 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Sharon Wappel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Medicine Research and Development, Zoetis Inc, Kalamazoo, MI. Hauptthemen laut MEDLINE: Bordetella bronchiseptica, Bordetella Infections, Bacterial Vaccines, Dog Diseases. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To evaluate the onset of immunity 7 days after administration of a live-attenuated Bordetella bronchiseptica (Bb) vaccine (Vanguard B Oral) in dogs.
Methods
In a randomized, blinded, controlled study conducted at an animal research facility in 2022, forty 8-week-old Beagle puppies were randomly assigned to 2 groups (n = 20/group) and administered a single oral dose of either placebo or vaccine on day 0. On day 7 after vaccination, all dogs were challenged with aerosolized virulent Bb. Clinical observations were conducted twice on days 0 and 6 through 20 and once daily on days 1 through 5 and 21. Tympanic temperatures were measured twice on day 0 and once daily from days 1 through 21. Microplate agglutination titers were collected from all animals on days −12, 0, 6, and 21.
Results
Coughing on 2 consecutive days occurred in 17 of 20 control dogs (85%) versus 4 of 20 vaccinates (20%). Vaccinated dogs also exhibited fewer coughing observation periods (3.2% vs 15.8%) and a shorter coughing duration of 2.4 days (95% CI, 1.0 to 3.7) than controls (5.5 days; 95% CI, 4.1 to 6.8). Total clinical scores were significantly lower in vaccinated (median, 15.0) dogs than in controls (median, 27.0) and remained significant when ocular and nasal discharge were excluded.
Conclusions
The vaccine was considered safe, with only sporadic mild clinical signs. After challenge, vaccinated dogs demonstrated a significant reduction in coughing and other clinical signs. Clinical Relevance Vanguard B Oral elicited a rapid onset of protective immunity against virulent Bb challenge as early as 7 days after vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterinary Medicine Research and Development, Zoetis Inc, Kalamazoo, MI.
- VMRD Regulatory Affairs, Zoetis Inc, Zaventem, Belgium.
- Veterinary Medicine Research and Development, Zoetis Manufacturing and Research, Girona, Spain.
- VMRD Animal Research Support, Zoetis Inc, Richland, MI.
- Veterinary Medicine Research and Development, Zoetis Inc, Lincoln, NE.
Zitieren
APA
Wappel, S., Velineni, S., King, V., Abma, E., Hoevers, J., Martorell, S., Houser, C., Tague, A., Wilmes, L., & Millership, J. (2026). Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.26.03.0100
Vancouver
Wappel S, Velineni S, King V, Abma E, Hoevers J, Martorell S, et al. Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.26.03.0100
BibTeX
@article{Wappel2026,
author = {Wappel, Sharon and Velineni, Sridhar and King, Vickie and Abma, Eline and Hoevers, Jacquelien and Martorell, Susanna and Houser, Cheyenne and Tague, Anne and Wilmes, Lauren and Millership, Jason},
title = {Oral administration of a live-attenuated Bordetella bronchiseptica vaccine (Vanguard B Oral) induces protective immunity against challenge 7 days after vaccination in dogs},
journal = {American Journal of Veterinary Research},
year = {2026},
doi = {10.2460/ajvr.26.03.0100}
}
EUVIMED